Medical Journals

Novel Mechanism of Inhibition of Rat Kidney-type Glutaminase by Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide (Bptes).

Authors:
  • Robinson Mary M
  • McBryant Steven J
  • Tsukamoto Takashi
  • Rojas Camilo
  • Ferraris Dana V
  • Hamilton Sean K
  • Hansen Jeffrey C
  • Curthoys Norman P

From: Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO 80523-1870, USA.

The Biochemical journal

  • Publish Date: Sep 2007
  • ISSN: 1470-8728
  • Volume: 406
  • Issue: 3
  • Pages: 407-14
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Robinson Mary M, McBryant Steven J, Tsukamoto Takashi, et al. Novel Mechanism of Inhibition of Rat Kidney-type Glutaminase by Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide (Bptes).. Biochem. J. Sep 2007;406:407-14

Abstract

The release of GA (mitochondrial glutaminase) from neurons following acute ischaemia or during chronic neurodegenerative diseases may contribute to the propagation of glutamate excitotoxicity. Thus an inhibitor that selectively inactivates the released GA may limit the accumulation of excess glutamate and minimize the loss of neurological function that accompanies brain injury. The present study examines the mechanism of inactivation of rat KGA (kidney GA isoform) by the small-molecule inhibitor BPTES [bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide]. BPTES is a potent inhibitor of KGA, but not of the liver GA isoform, glutamate dehydrogenase or gamma-glutamyl transpeptidase. Kinetic studies indicate that, with respect to glutamine, BPTES has a K(i) of approx. 3 microM. Moreover, these studies suggest that BPTES inhibits the allosteric activation caused by phosphate binding and promotes the formation of an inactive complex. Gel-filtration chromatography and sedimentation-velocity analysis were used to examine the effect of BPTES on the phosphate-dependent oligomerization of KGA. This established that BPTES prevents the formation of large phosphate-induced oligomers and instead promotes the formation of a single oligomeric species with distinct physical properties. Sedimentation-equilibrium studies determined that the oligomer produced by BPTES is a stable tetramer. Taken together, the present work indicates that BPTES is a unique and potent inhibitor of rat KGA and elucidates a novel mechanism of inactivation.

Mesh Headings (Keywords): Animals, Chromatography, Gel, Enzyme Inhibitors, Fractionation, Field Flow, Glutaminase, Kidney, Kinetics, Rats, Rats, Sprague-Dawley, Sulfides, Thiadiazoles, Ultracentrifugation


Check for Full Text / PubMed Unique Identifier (PMID): 17581113


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.